Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
Wani RA, Dar MA, Chandel RK, et al Title of paper should have been “Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a randomized, open-label study”. Read the original...
Main Authors: | Wani RA, Dar MA, Chandel RK, Rather YH, Haq I, Hussain A, Malla AA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-03-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/corrigendum-effects-of-switching-from-olanzapine-to-aripiprazole--peer-reviewed-article-NDT |
Similar Items
-
Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study
by: Wani RA, et al.
Published: (2015-03-01) -
Cost/effectiveness of aripiprazole vs. olanzapine in the long-term treatment of schizophrenia
by: Dutina Aleksandra, et al.
Published: (2019-01-01) -
Schizophrenia: effects of aripiprazole in metabolic syndrome
by: Deborah Galvão Coelho da Silva, et al.
Published: (2019-11-01) -
An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia
by: Giorgio L Colombo, et al.
Published: (2008-08-01) -
Effects of Aripiprazole on Olanzapine Population Pharmacokinetics and Initial Dosage Optimization in Schizophrenia Patients
by: Zhang C, et al.
Published: (2024-03-01)